| |
|
| |
/-122.39546967,37.78852463,13,0,0/550x200?access_token=pk.eyJ1IjoiZ2FyeXNndWlkZSIsImEiOiJjamtobmRiYmgwb3gwM3F1a2o2Mmd0YWw3In0.DinA62CR3-OKtf3axa5O7Q)
|
| |
| DETAILS |
|
Explore pharma's decision-making platform across the entire drug R&D process
Join us at SimulativeBio@JPM 2026 hosted by PriceWaterHouseCoopers.
2025 was a year of tremendous enthusiasm in the possibilities of leveraging generative AI. We believe 2026 will be the year where alternative approaches in AI will gain momentum to overcome the limitations in generative AI to solve complex scientific challenges such as the innovation necessary within drug development.
SimulativeBio is a community dedicated to advancing Simulative AI, creating Domain-specific Simulative Models (DsSM) of biology that enhance & extend scientists' problemsolving capabilities from target discovery through clinical trials & approval.
We are excited to bring together a great panel of experts across drug development, AI, regulatory, data science, & commercial execution to discuss how Simulative AI could be the only viable approach to handle the complexity of biology at scale.
We will announce the panel shortly. Stay tuned.
|
|
|
|
|
|
|
|
